Aenova Group

With a robust network of advanced manufacturing sites across Europe and the United States, Aenova Group operates as one of the world's most trusted contract development and manufacturing organisations (CDMOs) serving the pharmaceutical and healthcare industries. The group provides end-to-end solutions that span the entire product lifecycle, from early-stage formulation and process development through to large-scale commercial manufacturing.

End-to-End Manufacturing and Development Capabilities

Aenova's service portfolio covers contract production, pharmaceutical packaging, drug product development, and third-party manufacturing across a broad range of dosage forms. The group applies state-of-the-art facilities and cutting-edge technologies to deliver tailored solutions for pharmaceutical, consumer health, and veterinary markets worldwide, including a dedicated animal health division.

Global Reach Across Pharmaceutical, Consumer Health, and Veterinary Markets

Formed through a series of strategic mergers and acquisitions, Aenova has grown into a globally recognised CDMO partner with manufacturing capacity concentrated across European sites and the United States. The group's international footprint allows clients to access scalable, compliant manufacturing services throughout multiple regulatory jurisdictions. Aenova also maintains dedicated functions covering corporate sustainability, compliance, and investor relations, reflecting the governance infrastructure of a major industry participant.

Further information is available at aenova-group.com.